Reducing mortality from gram-negative bacterial infections.
D000005:Abdomen / Q000382:microbiology / Q000473:pathology; D000367:Age Factors; D000368:Aged; D000617:Aminoglycosides / Q000627:therapeutic use; D000906:Antibodies / Q000627:therapeutic use*; D001419:Bacteria / Q000302:isolation & purification*; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality*; D001847:Bone Diseases / Q000209:etiology; D004927:Escherichia coli Infections / Q000401:mortality; D006801:Humans; D007710:Klebsiella Infections / Q000401:mortality; D008875:Middle Aged; D011014:Pneumonia / Q000209:etiology; D011512:Proteus Infections / Q000401:mortality; D011552:Pseudomonas Infections / Q000401:mortality; D018805:Sepsis / Q000209:etiology; D014552:Urinary Tract Infections / Q000209:etiology
D000617:Aminoglycosides; D000906:Antibodies